Dennis D. Kim's most recent trade in Cymabay Therapeutics Inc was a trade of 112,219 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 112,219 | 169,900 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.54 per share. | 13 Apr 2023 | 112,219 | 20,000 (0%) | 0% | 9.5 | 1,070,536 | Common Stock |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 13 Apr 2023 | 112,219 | 132,219 (0%) | 0% | 4.4 | 490,397 | Common Stock |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.98 per share. | 13 Apr 2023 | 7,781 | 20,000 (0%) | 0% | 9.0 | 69,880 | Common Stock |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 7,781 | 282,119 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 13 Apr 2023 | 7,781 | 27,781 (0%) | 0% | 4.4 | 34,003 | Common Stock |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 100 | 289,900 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.99 per share. | 28 Mar 2023 | 100 | 20,000 (0%) | 0% | 9.0 | 899 | Common Stock |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 28 Mar 2023 | 100 | 20,100 (0%) | 0% | 4.4 | 437 | Common Stock |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 180,000 | 180,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 133,333 | 133,333 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dennis D. Kim | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.04 per share. | 19 Jan 2022 | 20,000 | 20,000 (0%) | 0% | 3.0 | 60,800 | Common Stock |